CATALDO TONY sold 39.4% of their position (4.23M shares) of GT BIOPHARMA, INC. on the open market
Open‑market sale worth $4.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/4/2020ACC: 0000939798-20-000007
-4.23M
Net shares
Net seller
$4.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.23M disposed
Non-Derivative Transactions1
common stock
Direct
Shares
−4.23M
Price / share
$0.00
Trade value
$4.23K
% of position
39.4%
6/2/2020
10.73M→6.50M
Total
Net shares
−4.23M
Net value
-$4.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| common stock Direct | 6/2/2020 | S · Sale | −4.23M | $0.00 | $4.23K | 39.4% | 10.73M | 6.50M |
| Total | −4.23M | -$4.23K | ||||||
Derivative Transactions0
No derivative transactions reported